Clinical Trials
94
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (61 trials with phase data)• Click on a phase to view related trials
IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.
- Conditions
- Acute Myeloid LeukemiaRelapse/Recurrence
- Interventions
- Drug: Low intensity therapiesDrug: High intensity therapies
- First Posted Date
- 2024-12-03
- Last Posted Date
- 2025-05-31
- Target Recruit Count
- 339
- Registration Number
- NCT06713837
- Locations
- 🇨🇿
University Hospital Brno, Brno, Czechia
🇨🇿University Hospital Hradec Králové, Hradec Králové, Czechia
🇨🇿University Hospital Olomouc, Olomouc, Czechia
Sequential Immunochemotherapy Treatment with Pembrolizumab Plus Dendritic Cell (DC) Vaccine Followed by Trifluridine/Tipiracil Plus Bevacizumab in Refractory Mismatch-repair-proficient (pMMR) or Microsatellite-stable (MSS) Metastatic Colorectal Cancer
- Conditions
- Microsatellite Stable Colorectal CarcinomaRefractory Mismatch-repair-proficient (pMMR) Metastatic Colorectal CancerColorectal Cancer Metastatic
- Interventions
- Biological: Autologous Dendritic Cell (DC) Vaccine
- First Posted Date
- 2024-07-26
- Last Posted Date
- 2025-01-28
- Target Recruit Count
- 36
- Registration Number
- NCT06522919
- Locations
- 🇮🇹
IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"-IRST S.r.l., Meldola, Forlì Cesena, Italy
🇮🇹Pia Fondazione di Culto e Religione Azienda Ospedaliera "Card.G.Panico", Tricase, Lecce, Italy
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
- Conditions
- Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia Refractory
- First Posted Date
- 2024-06-14
- Last Posted Date
- 2025-05-31
- Target Recruit Count
- 4000
- Registration Number
- NCT06459024
- Locations
- 🇩🇪
University Hospital Greifswald, Greifswald, Germany
🇩🇪University Hospital Halle, Halle, Germany
🇩🇪University Hospital of Rostock, Rostock, Germany
Avidination for RadionuclideTHerapy in Nonpalpable Breast Cancer
- First Posted Date
- 2024-04-30
- Last Posted Date
- 2025-02-03
- Target Recruit Count
- 18
- Registration Number
- NCT06390241
- Locations
- 🇮🇹
IRCCS Istituto ROmagnolo per lo Studio dei Tumori "Dino Amadori"-IRST S.r.l., Meldola, Forlì Cesena, Italy
National Database of Bone Metastases
- Conditions
- Bone Metastases
- First Posted Date
- 2024-04-16
- Last Posted Date
- 2024-04-16
- Target Recruit Count
- 800
- Registration Number
- NCT06367491
- Locations
- 🇮🇹
A.U.S.L. Imola, Imola, Bologna, Italy
🇮🇹Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, FC, Italy
🇮🇹Osp. "Sacro Cuore di Gesù", Gallipoli, Lecce, Italy
- Prev
- 1
- 2
- 3
- 4
- 5
- 16
- Next